List of Tables
Table 1. Global Oral Factor Xa Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Oral Factor Xa Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Oral Factor Xa Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global Oral Factor Xa Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Oral Factor Xa Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Oral Factor Xa Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Oral Factor Xa Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Oral Factor Xa Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Oral Factor Xa Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Oral Factor Xa Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Oral Factor Xa Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of Oral Factor Xa Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Factor Xa Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Factor Xa Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Factor Xa Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Oral Factor Xa Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global Oral Factor Xa Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global Oral Factor Xa Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global Oral Factor Xa Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global Oral Factor Xa Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global Oral Factor Xa Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global Oral Factor Xa Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global Oral Factor Xa Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America Oral Factor Xa Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Oral Factor Xa Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America Oral Factor Xa Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America Oral Factor Xa Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America Oral Factor Xa Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Oral Factor Xa Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Oral Factor Xa Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe Oral Factor Xa Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe Oral Factor Xa Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Oral Factor Xa Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Oral Factor Xa Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Oral Factor Xa Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Oral Factor Xa Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Oral Factor Xa Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Oral Factor Xa Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Oral Factor Xa Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Oral Factor Xa Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America Oral Factor Xa Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America Oral Factor Xa Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Oral Factor Xa Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Oral Factor Xa Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Oral Factor Xa Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Oral Factor Xa Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Oral Factor Xa Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Oral Factor Xa Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global Oral Factor Xa Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global Oral Factor Xa Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global Oral Factor Xa Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global Oral Factor Xa Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global Oral Factor Xa Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Oral Factor Xa Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Oral Factor Xa Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global Oral Factor Xa Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global Oral Factor Xa Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global Oral Factor Xa Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global Oral Factor Xa Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global Oral Factor Xa Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global Oral Factor Xa Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global Oral Factor Xa Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global Oral Factor Xa Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Oral Factor Xa Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Oral Factor Xa Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global Oral Factor Xa Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global Oral Factor Xa Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global Oral Factor Xa Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Oral Factor Xa Inhibitors Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Bristol Myers Squibb Company Information
Table 76. Bristol Myers Squibb Description and Business Overview
Table 77. Bristol Myers Squibb Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bristol Myers Squibb Oral Factor Xa Inhibitors Product
Table 79. Bristol Myers Squibb Recent Developments/Updates
Table 80. Daiichi Sankyo Company Information
Table 81. Daiichi Sankyo Description and Business Overview
Table 82. Daiichi Sankyo Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Daiichi Sankyo Oral Factor Xa Inhibitors Product
Table 84. Daiichi Sankyo Recent Developments/Updates
Table 85. Janssen Pharmaceuticals Company Information
Table 86. Janssen Pharmaceuticals Description and Business Overview
Table 87. Janssen Pharmaceuticals Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Janssen Pharmaceuticals Oral Factor Xa Inhibitors Product
Table 89. Janssen Pharmaceuticals Recent Developments/Updates
Table 90. Bayer Company Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Bayer Oral Factor Xa Inhibitors Product
Table 94. Bayer Recent Developments/Updates
Table 95. Mylan Company Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Mylan Oral Factor Xa Inhibitors Product
Table 99. Mylan Recent Developments/Updates
Table 100. Zydus Company Information
Table 101. Zydus Description and Business Overview
Table 102. Zydus Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Zydus Oral Factor Xa Inhibitors Product
Table 104. Zydus Recent Developments/Updates
Table 105. Lupin Company Information
Table 106. Lupin Description and Business Overview
Table 107. Lupin Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Lupin Oral Factor Xa Inhibitors Product
Table 109. Lupin Recent Developments/Updates
Table 110. Apotex Company Information
Table 111. Apotex Description and Business Overview
Table 112. Apotex Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Apotex Oral Factor Xa Inhibitors Product
Table 114. Apotex Recent Developments/Updates
Table 115. Accord Healthcare Company Information
Table 116. Accord Healthcare Description and Business Overview
Table 117. Accord Healthcare Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Accord Healthcare Oral Factor Xa Inhibitors Product
Table 119. Accord Healthcare Recent Developments/Updates
Table 120. Chia Tai Tianqing Pharmaceutical Company Information
Table 121. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 122. Chia Tai Tianqing Pharmaceutical Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Chia Tai Tianqing Pharmaceutical Oral Factor Xa Inhibitors Product
Table 124. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 125. Shanghai Huilun Pharmaceutical Company Information
Table 126. Shanghai Huilun Pharmaceutical Description and Business Overview
Table 127. Shanghai Huilun Pharmaceutical Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Shanghai Huilun Pharmaceutical Oral Factor Xa Inhibitors Product
Table 129. Shanghai Huilun Pharmaceutical Recent Developments/Updates
Table 130. Qilu Pharmaceutical Company Information
Table 131. Qilu Pharmaceutical Description and Business Overview
Table 132. Qilu Pharmaceutical Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Qilu Pharmaceutical Oral Factor Xa Inhibitors Product
Table 134. Qilu Pharmaceutical Recent Developments/Updates
Table 135. HEC Pharma Company Information
Table 136. HEC Pharma Description and Business Overview
Table 137. HEC Pharma Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. HEC Pharma Oral Factor Xa Inhibitors Product
Table 139. HEC Pharma Recent Developments/Updates
Table 140. Cspc Ouyi Pharmaceutical Company Information
Table 141. Cspc Ouyi Pharmaceutical Description and Business Overview
Table 142. Cspc Ouyi Pharmaceutical Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Cspc Ouyi Pharmaceutical Oral Factor Xa Inhibitors Product
Table 144. Cspc Ouyi Pharmaceutical Recent Developments/Updates
Table 145. Zhejiang Hisun Pharmaceutical Company Information
Table 146. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 147. Zhejiang Hisun Pharmaceutical Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Zhejiang Hisun Pharmaceutical Oral Factor Xa Inhibitors Product
Table 149. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 150. Hansoh Pharma Company Information
Table 151. Hansoh Pharma Description and Business Overview
Table 152. Hansoh Pharma Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Hansoh Pharma Oral Factor Xa Inhibitors Product
Table 154. Hansoh Pharma Recent Developments/Updates
Table 155. Huahai Pharmaceutical Company Information
Table 156. Huahai Pharmaceutical Description and Business Overview
Table 157. Huahai Pharmaceutical Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Huahai Pharmaceutical Oral Factor Xa Inhibitors Product
Table 159. Huahai Pharmaceutical Recent Developments/Updates
Table 160. Yangtze River Pharmaceutical Company Information
Table 161. Yangtze River Pharmaceutical Description and Business Overview
Table 162. Yangtze River Pharmaceutical Oral Factor Xa Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Yangtze River Pharmaceutical Oral Factor Xa Inhibitors Product
Table 164. Yangtze River Pharmaceutical Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Oral Factor Xa Inhibitors Distributors List
Table 168. Oral Factor Xa Inhibitors Customers List
Table 169. Oral Factor Xa Inhibitors Market Trends
Table 170. Oral Factor Xa Inhibitors Market Drivers
Table 171. Oral Factor Xa Inhibitors Market Challenges
Table 172. Oral Factor Xa Inhibitors Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Factor Xa Inhibitors
Figure 2. Global Oral Factor Xa Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Oral Factor Xa Inhibitors Market Share by Type: 2025 & 2032
Figure 4. Rivaroxaban Product Picture
Figure 5. Edoxaban Product Picture
Figure 6. Apixaban Product Picture
Figure 7. Global Oral Factor Xa Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Oral Factor Xa Inhibitors Market Share by Application: 2025 & 2032
Figure 9. Deep Vein Thrombosis
Figure 10. Pulmonary Embolism
Figure 11. Atrial Fibrillation
Figure 12. Other
Figure 13. Global Oral Factor Xa Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Oral Factor Xa Inhibitors Market Size (US$ Million), 2021–2032
Figure 15. Global Oral Factor Xa Inhibitors Sales (K Units), 2021–2032
Figure 16. Global Oral Factor Xa Inhibitors Average Price (US$/Unit), 2021–2032
Figure 17. Oral Factor Xa Inhibitors Report Years Considered
Figure 18. Oral Factor Xa Inhibitors Sales Share by Manufacturers in 2025
Figure 19. Global Oral Factor Xa Inhibitors Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Oral Factor Xa Inhibitors Players: Market Share by Revenue in Oral Factor Xa Inhibitors in 2025
Figure 21. Oral Factor Xa Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Oral Factor Xa Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Oral Factor Xa Inhibitors Sales Market Share by Country (2021–2032)
Figure 24. North America Oral Factor Xa Inhibitors Revenue Market Share by Country (2021–2032)
Figure 25. United States Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Oral Factor Xa Inhibitors Sales Market Share by Country (2021–2032)
Figure 28. Europe Oral Factor Xa Inhibitors Revenue Market Share by Country (2021–2032)
Figure 29. Germany Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Oral Factor Xa Inhibitors Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Oral Factor Xa Inhibitors Revenue Market Share by Region (2021–2032)
Figure 36. China Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Oral Factor Xa Inhibitors Sales Market Share by Country (2021–2032)
Figure 44. Latin America Oral Factor Xa Inhibitors Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Oral Factor Xa Inhibitors Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Oral Factor Xa Inhibitors Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Oral Factor Xa Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Oral Factor Xa Inhibitors by Type (2021–2032)
Figure 55. Global Revenue Market Share of Oral Factor Xa Inhibitors by Type (2021–2032)
Figure 56. Global Oral Factor Xa Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Oral Factor Xa Inhibitors by Application (2021–2032)
Figure 58. Global Revenue Market Share of Oral Factor Xa Inhibitors by Application (2021–2032)
Figure 59. Global Oral Factor Xa Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 60. Oral Factor Xa Inhibitors Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
